Mindray Medical (MR) Posts Q3 EPS of $0.38, Tops by 11c
Mindray Medical International Limited (NYSE: MR) reports Q3 EPS of $0.38, 11 cents better than the analyst estimate of $0.27. Revenue for the quarter was $151.1 million, which compares to the estimate of $154.98 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
